Literature DB >> 28186087

Baculovirus directly activates murine NK cells via TLR9.

T Moriyama1, T Suzuki1, M O Chang1, M Kitajima2, H Takaku3.   

Abstract

The importance of natural killer (NK) cells in innate immune responses against tumors or viral infections enhances the appeal of NK cell-based immunotherapeutic approaches. We have recently reported that baculovirus (BV)-infected dendritic cells (DCs; BV-DCs) induce antitumor immunity against established tumors in mice. These antitumor effects were CD8+ T-cell and NK cell dependent; however, they were found to be CD4+ T-cell independent. In this study, we investigated the involvement of Toll-like receptor 9 (TLR9) in the process of BV recognition by NK cells. We found that BV directly stimulated NK cells, induced the expression of the activation marker CD69 and promoted interferon-gamma (IFN-γ) production and cytotoxicity. Moreover, TLR9 knockout in mice (tlr9-/- NK cells) inhibited NK cell responses to BV, indicating that TLR9 may have a relevant role in the BV-induced upregulation of NK cell functions. Our data demonstrated for the first time that NK cells directly recognize BV via TLR9, which provides opportunities for the use of this technique as an effective tool for BV-based immunotherapies against malignancies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28186087     DOI: 10.1038/cgt.2017.2

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  23 in total

Review 1.  Host innate immune responses induced by baculovirus in mammals.

Authors:  Takayuki Abe; Yoshiharu Matsuura
Journal:  Curr Gene Ther       Date:  2010-06       Impact factor: 4.391

2.  Influence of NK cell magnetic bead isolation methods on phenotype and function of murine NK cells.

Authors:  Kathrin Meinhardt; Irena Kroeger; Alexandra Abendroth; Sabine Müller; Andreas Mackensen; Evelyn Ullrich
Journal:  J Immunol Methods       Date:  2012-01-28       Impact factor: 2.303

Review 3.  Natural killer cell memory in infection, inflammation and cancer.

Authors:  Adelheid Cerwenka; Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2016-01-25       Impact factor: 53.106

Review 4.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

Review 5.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 6.  Human natural killer cell deficiencies.

Authors:  Jordan S Orange
Journal:  Curr Opin Allergy Clin Immunol       Date:  2006-12

7.  Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.

Authors:  Emanuela Marcenaro; Bruna Ferranti; Michela Falco; Lorenzo Moretta; Alessandro Moretta
Journal:  Int Immunol       Date:  2008-07-01       Impact factor: 4.823

8.  Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus.

Authors:  Masayuki Kitajima; Takayuki Abe; Naoko Miyano-Kurosaki; Masaru Taniguchi; Toshinori Nakayama; Hiroshi Takaku
Journal:  Mol Ther       Date:  2007-12-04       Impact factor: 11.454

9.  Natural killer cell-based therapies.

Authors:  François Romagné; Eric Vivier
Journal:  F1000 Med Rep       Date:  2011-05-03

10.  Natural killer cells: from basic research to treatments.

Authors:  Eric Vivier; Sophie Ugolini
Journal:  Front Immunol       Date:  2011-06-03       Impact factor: 7.561

View more
  7 in total

1.  Baculovirus Transduction in Mammalian Cells Is Affected by the Production of Type I and III Interferons, Which Is Mediated Mainly by the cGAS-STING Pathway.

Authors:  Sabrina Amalfi; Guido Nicolás Molina; Romina Jimena Bevacqua; María Gabriela López; Oscar Taboga; Victoria Alfonso
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

2.  An HER2-Displaying Virus-Like Particle Vaccine Protects from Challenge with Mammary Carcinoma Cells in a Mouse Model.

Authors:  Lisa Nika; Sara Cuadrado-Castano; Guha Asthagiri Arunkumar; Clemens Grünwald-Gruber; Meagan McMahon; Krisztina Koczka; Adolfo García-Sastre; Florian Krammer; Reingard Grabherr
Journal:  Vaccines (Basel)       Date:  2019-05-20

3.  Recombinant baculovirus expressing the FrC-OVA protein induces protective antitumor immunity in an EG7-OVA mouse model.

Authors:  Keigo Kondou; Tomoyuki Suzuki; Myint Oo Chang; Hiroshi Takaku
Journal:  J Biol Eng       Date:  2019-10-22       Impact factor: 4.355

4.  The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections.

Authors:  Miriam Klausberger; Irina A Leneva; Irina N Falynskova; Kirill Vasiliev; Alexander V Poddubikov; Claudia Lindner; Nadezhda P Kartaschova; Oxana A Svitich; Marina Stukova; Reingard Grabherr; Andrej Egorov
Journal:  Vaccines (Basel)       Date:  2019-11-17

5.  Dual TLR2/9 Recognition of Herpes Simplex Virus Infection Is Required for Recruitment and Activation of Monocytes and NK Cells and Restriction of Viral Dissemination to the Central Nervous System.

Authors:  Erdenebileg Uyangaa; Jin Young Choi; Ajit Mahadev Patil; Ferdaus Mohd Altaf Hossain; Sung Ok Park; Bumseok Kim; Koanhoi Kim; Seong Kug Eo
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

6.  Toll-like receptor 4 (TLR4) expression is correlated with T2* iron deposition in response to doxorubicin treatment: cardiotoxicity risk assessment.

Authors:  Nelu-Mihai Trofenciuc; Aurora Diana Bordejevic; Mirela Cleopatra Tomescu; Lucian Petrescu; Simina Crisan; Oliviana Geavlete; Alexandru Mischie; Alexandru Fica Mircea Onel; Alciona Sasu; Adina Ligia Pop-Moldovan
Journal:  Sci Rep       Date:  2020-10-12       Impact factor: 4.379

7.  IRF8 Impacts Self-Renewal of Hematopoietic Stem Cells by Regulating TLR9 Signaling Pathway of Innate Immune Cells.

Authors:  Donghe Li; Yuyin Zhang; Qingsong Qiu; Jinzeng Wang; Xuemei Zhao; Bo Jiao; Xiuli Zhang; Shanhe Yu; Pengfei Xu; Yuqing Dan; Xinhua Xiao; Peihong Wang; Mingzhu Liu; Zhizhou Xia; Zhangsen Huang; Ruihong Zhang; Jiaoyang Li; Xi Xie; Yan Zhang; Chenxuan Liu; Ping Liu; Ruibao Ren
Journal:  Adv Sci (Weinh)       Date:  2021-08-08       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.